Close Menu
Home » Beckman Coulter Life Sciences Acquires Labcyte

Beckman Coulter Life Sciences Acquires Labcyte

Jan 30, 2019
|
staff reporter

NEW YORK (GenomeWeb) — Beckman Coulter Life Sciences announced today that it has acquired privately held liquid handling firm Labcyte.

Based in San Jose, California, Labcyte has developed an acoustic droplet ejection technology called Echo that uses sound energy for the contactless transfer of samples and reagents. Specific terms of the acquisition were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Hahn Hearing

Stephen Hahn, the nominee to lead the US Food and Drug Administration, underwent a Senate confirmation hearing yesterday, the Washington Post reports.

RNAi Drug for Acute Hepatic Porphyria

The US Food and Drug Administration has approved an RNA interference drug to treat acute hepatic porphyria.

Decade of DTC

Gizmodo looks over the past decade of consumer DNA testing to find the field to be lacking.

Nature Studies Examine Native RNA Sequencing, Nanopore Sequencing Approach to Analyze STR Expansions

In Nature this week: native RNA sequencing and analysis of a human poly(A) transcriptome, nanopore sequencing-based method to analyze short tandem repeat expansions, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.